Premium
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure
Author(s) -
Robertson Charlene M. T.,
Juzer M. Tyebkhan,
Peliowski Abraham,
Philip C. Etches,
Cheung PoYin
Publication year - 2006
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2006.tb02210.x
Subject(s) - medicine , sensorineural hearing loss , hearing loss , ototoxicity , vancomycin , pediatrics , respiratory failure , diuretic , anesthesia , audiology , chemotherapy , staphylococcus aureus , biology , bacteria , cisplatin , genetics
Aim: To determine relationships between ototoxic drugs and 4‐y sensorineural hearing loss (SNHL) in near‐term and term survivors of severe neonatal respiratory failure. Methods: All 81 survivors of the Canadian arm of the Neonatal Inhaled Nitric Oxide Study (mortality 32, loss to follow‐up 9) received loop diuretics, aminoglycosides, and neuromuscular blockers (NMB), and 50 received vancomycin as neonates. Prospective, longitudinal secondary outcome using audiological tests diagnosed late‐onset, progressive SNHL in 43 (53%); not flat (sloping) in 29, flat (severe to profound) in 14. Risk for SNHL was determined. Results: A combination of duration of diuretic use of >14 d and average NMB dose of >0.96 mg/kg/d contributed to SNHL among survivors (odds ratio 5.2; 95% CI 1.6, 16.7). Markers of illness severity did not contribute. Dosage or duration of aminoglycosides use did not relate to SNHL. Cumulative dosages and duration of use of diuretics; NMB; use of vancomycin; and overlap of diuretics with NMB, aminoglycosides, and vancomycin individually linked to SNHL ( p <0.001). Conclusion: Overuse of loop diuretics and/or NMB contributes to SNHL after neonatal respiratory failure; markers of illness severity or the appropriate administration of aminoglycosides do not.